Japanese Society of Nuclear Medicine (JSNM)

the JSNM was established in 1964. Since then, our Society has constantly grown to now include 3,600 members with its mission to develop appropriate applications of radioactive substances and stable nuclides in medicine. To accomplish our goal, the JSNM has promoted a broad range of research in the clinical and investigational use of radiopharmaceuticals and related fields through exchanging ideas and information among physicians, physicists, chemists, pharmacists, technologists, nurses and others.

Currently, the optimization of treatments based on the accurate diagnosis is essential for many types of diseases. Since nuclear medicine plays an important role in both diagnosis and therapy, this unique medical technology by using isotopes has strongly attracted attention from a wide range of professionals involved in the medical sciences. For example, integration of diagnosis and treatment using radioisotopes, which is termed radio-theranostics, is an effective strategy for treatment of some intractable tumors. Additionally, some radioactive probes can non-invasively reveal the mystery of brain function, and the obtained findings can contribute to overcome neurological disorders such as dementia.